跳至主要内容
临床试验/IRCT20210218050404N4
IRCT20210218050404N4尚未招募3 期

Evaluation of therapeutic effects of ZAX.1400.C05 on symptomatic treatment and clinical features of patients with coronavirus: a randomized controlled clinical trial

Fasa University of Medical Sciences0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Definitive diagnosis of COVID-19 disease by laboratory diagnostic kit from patient sputum
  • Patient hemoglobin saturation (SPO2) between 85% and 93% in patients
  • Detection of lung involvement by CT scan in patients
  • The number of breaths per minute is between 25 and 30 in patients

排除标准

  • History of allergies to herbal products
  • Pregnancy and lactation
  • Existence of liver and kidney diseases
  • Inability of the patient to receive oral medication

研究者

发起方
Fasa University of Medical Sciences

相似试验